Who owns the LYGLAMET trademark?

The LYGLAMET trademark is owned by Bristol-Myers Squibb Company.

What class is the LYGLAMET trademark registered in?

The LYGLAMET trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for LYGLAMET?

The USPTO serial number for LYGLAMET is 77658047.

What is the registration number for LYGLAMET?

LYGLAMET is registered under USPTO registration number 0.

Sealvo

Home Search: LYGLAMETLYGLAMET #77658047

Back

Updated Oct 29, 2026·9 searches this week

View on USPTO TSDR Find similar marks

LYG

USPTO Trademark Record

ABANDONED

LYGLAMET

SN 77658047·Reg 0·Filed Jan 28, 2009

Owner Bristol-Myers Squibb Company

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

LYGLAMET (Serial No. 77658047), Registration No. 0, is a abandoned US trademark filed on Jan 28, 2009 by Bristol-Myers Squibb Company. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

Mark Intelligence

LYGLAMET (Reg. #0) is an abandoned US trademark that was filed in 2009 but has since been abandoned. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jan 28, 2009

SERIAL

77658047

REG#

Filing Information

StatusABANDONED

Filing DateJan 28, 2009

Serial Number77658047

Registration No.0

Status DateSep 26, 2011

Published for OppositionDec 01, 2009

Mark TypeStandard characters

Filing Basis & Declarations

Standard Characters ClaimedTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 006, 018, 044, 046, 051, 052

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

28 events

ABANDONMENT - NO USE STATEMENT FILED

Sep 26, 2011

ABANDONMENT - NO USE STATEMENT FILED

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Sep 26, 2011

ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

Feb 01, 2011

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

SOU EXTENSION 2 GRANTED

Jan 31, 2011

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Jan 27, 2011

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Jan 27, 2011

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

Aug 18, 2010

NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED

SOU EXTENSION 1 GRANTED

Aug 17, 2010

SOU EXTENSION 1 GRANTED

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Aug 17, 2010

CASE ASSIGNED TO INTENT TO USE PARALEGAL

SOU EXTENSION 1 FILED

Jul 22, 2010

SOU EXTENSION 1 FILED

SOU TEAS EXTENSION RECEIVED

Jul 22, 2010

SOU TEAS EXTENSION RECEIVED

ASSIGNED TO EXAMINER

Jul 21, 2010

ASSIGNED TO EXAMINER

NOA MAILED - SOU REQUIRED FROM APPLICANT

Feb 23, 2010

NOA MAILED - SOU REQUIRED FROM APPLICANT

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Dec 17, 2009

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Dec 17, 2009

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

PUBLISHED FOR OPPOSITION

Dec 01, 2009

PUBLISHED FOR OPPOSITION

NOTICE OF PUBLICATION

Nov 11, 2009

NOTICE OF PUBLICATION

ASSIGNED TO LIE

Oct 26, 2009

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Oct 26, 2009

LAW OFFICE PUBLICATION REVIEW COMPLETED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 07, 2009

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Sep 14, 2009

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Sep 14, 2009

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Sep 14, 2009

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Apr 16, 2009

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION MAILED

Apr 16, 2009

NON-FINAL ACTION MAILED

ASSIGNED TO EXAMINER

Apr 13, 2009

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Feb 03, 2009

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Jan 31, 2009

NEW APPLICATION ENTERED

Other Marks by Bristol-Myers Squibb Company

Additional USPTO filings from the same owner.

TOM

TOMORROW'S INNOVATORS IN SCIENCE, TECHNOLOGY, ENGINEERING AND MATH

98978549

Bristol-Myers Squibb Company

REGISTERED

EMP

EMPLICITI

99424859

BRISTOL-MYERS SQUIBB COMPANY

REGISTERED

SPR

SPRYCEL

78140234

Bristol-Myers Squibb Company

REGISTERED

OPD

OPDIVO

86174642

Bristol-Myers Squibb Company

REGISTERED

Other Marks by Tanya Fickenscher Leonard

Additional USPTO filings handled by the same attorney of record.

IVO

IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

77762649

OTHERS

BYO